These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14295204)

  • 1. ESTRADURIN (POLYOESTRADIOL PHOSPHATE) IN THE TREATMENT OF PROSTATIC CARCINOMA. A CLINICAL AND STEROID METABOLIC STUDY.
    JOENSSON G
    Urol Int; 1965; 19():11-8. PubMed ID: 14295204
    [No Abstract]   [Full Text] [Related]  

  • 2. ESTRADURIN (POLYOESTRADIOL PHOSPHATE) IN THE TREATMENT OF PROSTATIC CARCINOMA. A CLINICAL AND STEROID METABOLIC STUDY.
    JOENSSON G; DICZFALUSY E; PLANTIN LO; ROEHL L; BIRKE G
    Acta Endocrinol (Copenh); 1963; 44():SUPPL 83:1-41. PubMed ID: 14055590
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of primary orchiectomy and polyoestradiol phosphate in the treatment of advanced prostatic cancer. Finnprostate Group.
    Haapiainen R; Rannikko S; Alfthan O
    Br J Urol; 1990 Jul; 66(1):94-7. PubMed ID: 2132303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ENDOCRINE TREATMENT OF PROSTATIC CANCER].
    DE VOOGT HJ
    Jaarb Kankeronderz Kankerbestrijd Ned; 1963; 13():111-26. PubMed ID: 14182736
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of orchiectomy versus high dose polyoestradiol phosphate (160 mg) in relieving infravesical obstruction in patients with prostatic cancer.
    Aro J; Haapiainen R; Rannikko S; Alfthan O
    Int Urol Nephrol; 1990; 22(1):57-60. PubMed ID: 2199394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. re: Comparison of primary orchiectomy and polyoestradiol phosphate in the treatment of advanced prostatic cancer. R. Haapiainen et al. Br. J. Urol., 66, 94-97, 1990.
    Bishop MC
    Br J Urol; 1991 Aug; 68(2):218. PubMed ID: 1884161
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum sex hormone binding globulin and testosterone binding after estradiol administration, castration, and their combination in men with prostatic carcinoma.
    Leinonen P; Hammond GL; Lukkarinen O; Vihko R
    Invest Urol; 1979 Jul; 17(1):24-7. PubMed ID: 571863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a long-acting LHRH agonist and polyoestradiol phosphate in the treatment of advanced prostatic carcinoma. An open prospective, randomized multicentre study.
    Lukkarinen O; Kontturi M
    Scand J Urol Nephrol; 1994 Jun; 28(2):171-8. PubMed ID: 7939468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PROSTATIC CANCER OF A YOUNG PERSON WITH PRIMARY HYPOGONADISM.
    NISHIMURA R; KONDO I; OYAMATSU T
    Yokohama Med Bull; 1964 Apr; 15():63-70. PubMed ID: 14166645
    [No Abstract]   [Full Text] [Related]  

  • 10. [ESTROGEN-INDUCED CHANGES IN PROSTATE PATIENTS. PHYSICAL AND MENTAL EFFECTS IN 29 PATIENTS TREATED WITH ESTRADURIN-POLYESTRADIOL PHOSPHATE].
    PETERSEN P; ZINGG E
    Urol Int; 1965; 19():317-25. PubMed ID: 14316549
    [No Abstract]   [Full Text] [Related]  

  • 11. High dose polyoestradiol phosphate with and without acetosalicylic acid versus orchiectomy in the treatment of prostatic cancer. Finnprostate Group.
    Aro JL; Haapiainen RK; Rannikko SA; Alfthan OS
    Br J Urol; 1989 May; 63(5):512-4. PubMed ID: 2659136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ORCHIECTOMY IN THE TREATMENT OF PROSTATIC CANCER].
    PAVONE M
    Urol Int; 1965; 19():19-29. PubMed ID: 14295211
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term effects of endocrine treatment on serum steroids in advanced prostatic carcinoma patients.
    Lukkarinen O; Hammond GL; Kontturi M; Vihko R
    Invest Urol; 1980 Jan; 17(4):328-31. PubMed ID: 6444293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ethinyl oestradiol/polyoestradiol phosphate and estramustine phosphate on some proteins related to haemostasis in prostatic carcinoma patients.
    Damber JE; Daehlin L; Tomic R; Nilsson TK
    Int Urol Nephrol; 1991; 23(3):251-6. PubMed ID: 1889971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the effects of oestrogen in the male. Some effects of different oestrogenic substances in rats and men with prostatic carcinoma.
    Daehlin L
    Scand J Urol Nephrol Suppl; 1985; 91():1-44. PubMed ID: 3868029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O,P'DDD IN THE TREATMENT OF ADVANCED MAMMARY CARCINOMA.
    WEISENFELD S; HECHT A; LEICHTER D; GOLDNER M
    Cancer; 1964 Oct; 17():1258-66. PubMed ID: 14236758
    [No Abstract]   [Full Text] [Related]  

  • 17. TREATMENT OF CARCINOMA OF THE PROSTATE. A STUDY OF 128 FOLLOW-UP CASES.
    PERTTALA Y
    Ann Chir Gynaecol Fenn; 1964; 53():241-51. PubMed ID: 14163877
    [No Abstract]   [Full Text] [Related]  

  • 18. URINARY 17-KETOSTEROID EXCRETION IN INTACT, ADRENALECTOMIZED AND CAPONIZED CHICKENS.
    HERRICK EH; BRANDE PF
    Endocrinology; 1963 Aug; 73():273-4. PubMed ID: 14076211
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of advanced prostatic carcinoma using polyestradiol phosphate (Estradurin)].
    Bülow H
    Med Welt; 1980 Aug; 31(34):1215-7. PubMed ID: 6776381
    [No Abstract]   [Full Text] [Related]  

  • 20. [THE TESTICULAR FEMINIZATION SYNDROME].
    HENRION R
    Gynecol Obstet (Paris); 1963; 62():505-34. PubMed ID: 14077901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.